Amend Surgical Inc., of Alachua, Fla., has licensed a hydrogel-based tough adhesive technology from the Wyss Institute for Biologically Inspired Engineering at Harvard University. The licensing agreement gives Amend exclusive rights to initiate development of the technology for applications within the field of oral surgery. The company aims to redefine the current standard of care, which today often requires painful and irritating sutures to be placed by the clinician in the tight, difficult-to-access oral cavity. The company intends to ultimately manufacture the tough adhesive at its facility in Alachua, where it already employs a complementary manufacturing process.
Franklin Lakes, N.J.-based Becton, Dickinson and Co. (BD) reported additional pandemic orders for needles and syringes from the U.S. and Canada totaling 177 million injection devices. The new U.S. order for 140 million injection devices brings total U.S. orders from BD to 190 million devices. The new Canadian order for 37 million brings total Canadian orders from BD to 75 million devices. Across the world, BD has received total orders of 330 million needles and syringes from the U.S., Canada and the U.K. Most of these orders will be delivered by the end of December 2020 in anticipation of a vaccine being approved late this year or early 2021.
Minneapolis-based Bio-Techne Corp. reported that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the Exocovid-19 test for detection of the virus in patient samples. The Exocovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory.
Oxford, U.K.-based Blue Earth Diagnostics Ltd., a company focused on molecular imaging diagnostics, reported the first patients have been dosed at clinical trial sites in its phase III SPOTLIGHT clinical trial of rhPSMA-7.3 (18F), an investigational prostate-specific membrane antigen-targeted radiohybrid PET imaging agent. The SPOTLIGHT study is a multicenter, single-arm imaging study being conducted in the U.S. and Europe to evaluate the safety and diagnostic performance of rhPSMA-7.3 (18F) PET imaging in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy.
Orange City, Iowa-based Civco Radiotherapy and Mevion Medical Systems, of Littleton, Mass., said that Universal Couchtop now is validated and available on Mevion S250 Series Proton Therapy systems.
Clarify Health Solutions, of San Francisco, reported the release of an enhanced version of Clarify Referrals, a software as a service referral analytics product that uncovers actionable opportunities to improve in-network volume using the most precise referral logic and highest coverage claims data on the market.
Corinth Medtech, of San Jose, Calif., reported the commencement of evaluations of its U.S. FDA-cleared Veloxion system for transurethral resection of the prostate procedures. The company expects the U.S. premarket evaluations success will culminate in commercial launch of the Veloxion system in the fourth quarter.
Cvrx Inc., of Minneapolis, said that the BeAT-HF phase III randomized clinical trial has completed enrollment in the postmarket phase. The company also has enrolled the first patient in a heart failure registry which is designed to be a national repository of individual patient data from commercial Barostim Neo cases.
D-Link Systems, of Taipei, Taiwan, revealed the new Dcs-9500T Group Temperature Screening Camera kit that can simultaneously scan up to 30 people, eliminating queues in busy public areas.
Dxc Technology, of Tysons, Va., unveiled a definitive agreement to sell its health care software provider business to Florence, Italy-based Dedalus Group for $525 million in cash.
Electronic Caregiver, of Las Cruces, N.M., has developed a web application to help the world get back to work and school. The company's new Protector Initiative Infectious Disease Mitigation Program is a technology platform that prescreens individuals for symptoms and risk of COVID-19 before they enter a facility.
New York-based Enzo Biochem Inc. and Community Pharmacy Enhanced Services Network, the New York division of the clinically integrated, nationwide organization of pharmacy networks, are partnering to provide COVID-19 testing at 52 of the network’s 155 pharmacies across New York State.
Exactech Inc., of Gainesville, Fla., reported the transition of its Equinoxe Stemless Shoulder to a 3D laser printing manufacturing process.
Global Wholehealth Partners Corp., of San Clemente, Calif., said that it is authorized to sell the COVID-19 rt-PCR from 1 Drop Inc., of South Korea.
Seattle-based Know Labs Inc. has entered a research agreement with Mayo Clinic to test and validate its Bio-RFID platform technology. Know Labs plans to first deploy its Bio-RFID platform in its wearable Uband as a noninvasive continuous glucose monitor.
Ndd Medical Technologies Inc., of Andover, Mass., has introduced single patient-use, inline filters for its Easyone lung function testing devices in response to COVID-19.
Ventura, Calif.-based Nexa3D Inc. and Henkel, of Düsseldorf, Germany, reported the immediate commercial availability of Xmed412, a polypropylene-like material for biocompatible, medical and wearable devices. Manufactured by Henkel, Xmed412 is based its Loctite Med412 material and covered by all associated clearances, tests and certifications, the companies said.
Tokyo-based Nichiban Co. Ltd., a producer of adhesive bandages and surgical tapes, is opening a European subsidiary, Nichiban Europe GmbH, in Düsseldorf, Germany, in October 2020.
Nihon Kohden Corp., of Tokyo, has launched its Nk Aws-S200 video laryngoscope in the U.S. to help clinicians quickly and safely intubate patients with COVID-19 and other critical conditions. The device is designed to reduce exposure to aerosolized particles, a major concern when dealing with the coronavirus.
Oncology Venture A/S, of Hørsholm, Denmark, is using Fort Lauderdale, Fla.-based Citrix Systems Inc.’s digital workspace solutions on Google Cloud’s platform, with an eye toward delivering secure and reliable access to the applications and data the specialists it relies on to develop personalized treatments need and prefer to use in a single, unified experience.
Miami-based Opko Health Inc.’s Bioreference Laboratories has been awarded a contract by the CDC to provide commercial surge capacity testing for COVID-19 emergency response. Under the contract, which runs from July 20, 2020, through Nov. 19, 2020, Bioreference will perform antibody testing to determine COVID-19 seroprevalence and will provide results with key demographic information and analysis in collaboration with the CDC.
Atlanta-based Patientco, a patient payment technology company, has signed an agreement with Bjc Healthcare, of St. Louis, to make it easier for Bjc patients to navigate, understand and pay their medical expenses.
Perkinelmer Inc., of Waltham, Mass., has released a dry blood spot-based test for SARS-CoV-2 IgG antibodies using its Gsp/Delfia platform, enabling the processing of up to 5,000 samples per day. The finger-prick sample collection device allows for both decentralized sample collection and high-throughput testing. The company is marketing the product as a CE-IVD test and plans to apply for emergency use authorization with the U.S. FDA.
Seattle-based Sentinel Healthcare, a digital health care company, is teaming up with Vituity, a physician-owned and -led multispecialty partnership headquartered in Emeryville, Calif., to co-develop a platform that enables remote patient monitoring via an app on a patient’s smartphone. As part of the collaboration, Vituity is making an investment in Sentinel to advance its remote care programs and bring health care into the home following hospital discharge.
Houston-based Soliton Inc. said it expects to launch its Rapid Acoustic Pulse device in the U.S. in the first half of 2021. The launch will include the tattoo removal and cellulite reduction indications, pending FDA clearance of the latter.
Netanya, Israel-based Sorrel Medical Ltd., a provider of wearable drug delivery devices, said it is partnering with a an unamed global pharmaceutical company to advance the development and introduction of next-generation wearable drug delivery solutions. The collaboration will involve various molecule development initiatives across a range of configurations of Sorrel’s platform.
Streamline Healthcare Solutions, of Oakbrook Terrace, Ill., has launched a new Telehealth Services feature within its all-inclusive EHR, Smartcare.
Suralign Holdings Inc. (formerly RTI Surgical Holdings Inc.), of Deerfield, Ill., has completed the sale of its original equipment manufacturing business to London-based Montague Private Equity LLP for $440 million in cash. Additionally, beginning July 23, 2020, Suralign company will begin trading on Nasdaq under the new ticker symbol SRGA.
Michael Mina, of the Harvard T. Chan School of Public Health, reported the enrollment of the first 500 patients just 10 days after launching a COVID-19 longitudinal serological surveillance study using the Project Covalence trial platform from Trialspark Inc., of New York. The study aims to estimate the true prevalence of COVID-19 in the general population and investigate the role of COVID-19 antibodies and what protection they may offer.
Indianapolis-based Trimedx LLC is partnering with Medigate, of New York, to meet the demands of clinical asset management (CAM) and medical device safety and security for health care systems. The companies will deliver an integrated solution that merges the Trimedx CAM and Cyber Advanced solutions with Medigate’s real-time visibility, utilization data and threat and vulnerability detection.
UV-Concepts Inc., of Englewood, Colo., has inked an exclusive agreement with Dublin-based Hytech Ireland to distribute its UV-C Enclosure for large, portable medical equipment cleaning and disinfecting across Ireland and the U.K.
Vynleads Inc., a health and wellness technology company based in Rock Hill, S.C., said it is now trading on the OTCQB Venture Market under the ticker symbol VYND.